Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Morgan

Showing results (141-150 of 307) with videos related to

Pageof 31
Sort By:
BJU International|September 24, 2013
Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomyJacob T Ark, Kirk A Keegan, Daniel A Barocas, et al.
European Urology Oncology|May 11, 2024
Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data SetRandy A Vince, Helen Sun, Udit Singhal, et al.
JNCI Cancer Spectrum|May 26, 2022
Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation TherapyKristian D Stensland, Theresa Devasia, Megan E V Caram, et al.
JCO Precision Oncology|August 25, 2020
Clinical Utility of Gene Expression Classifiers in Men With Newly Diagnosed Prostate CancerJonathan C Hu, Jeffrey J Tosoian, Ji Qi, et al.
Cancer|February 6, 2026
Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomyBrian R Lane, Patrick Lewicki, Sabrina L Noyes, et al.
BMC Cancer|May 5, 2022
Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancerVipulkumar Dadhania, Daniel Gonzalez, Mustafa Yousif, et al.
Urologic Oncology|February 26, 2023
Use of a physical activity monitor to track perioperative activity of radical cystectomy patients. Our first glimpse at what our patients are doing before and after surgeryAlex Zhu, Joel E Berends, Stephanie Daignault-Newton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2019
Molecular Biomarkers in Localized Prostate Cancer: ASCO GuidelineScott E Eggener, R Bryan Rumble, Andrew J Armstrong, et al.
Urology|December 26, 2016
Potential Implications of Shortening Length of Stay Following Radical Cystectomy in a Pre-ERAS PopulationTakahiro Osawa, Sapan N Ambani, Kola Olugbade, et al.
Cancer Cytopathology|October 20, 2022
Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlatesRichard L Cantley, Xiaoming Wang, Zachery R Reichert, et al.
Pageof 31

Showing results (141-150 of 307) with videos related to

Sort By:
Pageof 31
BJU International|September 24, 2013
Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomyJacob T Ark, Kirk A Keegan, Daniel A Barocas, et al.
European Urology Oncology|May 11, 2024
Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data SetRandy A Vince, Helen Sun, Udit Singhal, et al.
JNCI Cancer Spectrum|May 26, 2022
Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation TherapyKristian D Stensland, Theresa Devasia, Megan E V Caram, et al.
JCO Precision Oncology|August 25, 2020
Clinical Utility of Gene Expression Classifiers in Men With Newly Diagnosed Prostate CancerJonathan C Hu, Jeffrey J Tosoian, Ji Qi, et al.
Cancer|February 6, 2026
Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomyBrian R Lane, Patrick Lewicki, Sabrina L Noyes, et al.
BMC Cancer|May 5, 2022
Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancerVipulkumar Dadhania, Daniel Gonzalez, Mustafa Yousif, et al.
Urologic Oncology|February 26, 2023
Use of a physical activity monitor to track perioperative activity of radical cystectomy patients. Our first glimpse at what our patients are doing before and after surgeryAlex Zhu, Joel E Berends, Stephanie Daignault-Newton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2019
Molecular Biomarkers in Localized Prostate Cancer: ASCO GuidelineScott E Eggener, R Bryan Rumble, Andrew J Armstrong, et al.
Urology|December 26, 2016
Potential Implications of Shortening Length of Stay Following Radical Cystectomy in a Pre-ERAS PopulationTakahiro Osawa, Sapan N Ambani, Kola Olugbade, et al.
Cancer Cytopathology|October 20, 2022
Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlatesRichard L Cantley, Xiaoming Wang, Zachery R Reichert, et al.
Pageof 31